Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 72,798 shares, an increase of 3,416.8% from the April 30th total of 2,070 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 84,663 shares, the days-to-cover ratio is currently 0.9 days.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Jefferies Financial Group cut Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. BNP Paribas Exane raised Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Finally, Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Sonova Price Performance

OTCMKTS SONVY traded up $0.44 during trading hours on Wednesday, reaching $53.38. 21,770 shares of the company’s stock were exchanged, compared to its average volume of 42,539. The company’s 50-day moving average is $46.39 and its two-hundred day moving average is $49.92. Sonova has a one year low of $42.26 and a one year high of $63.69. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.